サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1300767

5価ワクチンの世界市場規模調査＆予測：タイプ別、製剤タイプ別、用途別、地域別分析、2023-2030年

Global Pentavalent Market Size Study & Forecast, by Type, by Formulation Type, by Application and Regional Analysis, 2023-2030

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
5価ワクチンの世界市場規模調査＆予測：タイプ別、製剤タイプ別、用途別、地域別分析、2023-2030年
出版日: 2023年06月27日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

5価ワクチンの世界市場は、2022年に約24億3,000万米ドルと評価され、予測期間2023-2030年には5.1%以上の健全な成長率で成長すると予測されています。

5価ワクチンは、ジフテリア、百日咳、破傷風、B型肝炎、インフルエンザ菌b型（Hib）の5種類の病気を予防するワクチンです。1回の注射で5種類のワクチンを接種できるため、「5価」ワクチンと呼ばれています。5価ワクチン市場は、政府のイニシアチブの増加、予防接種プログラムの増加、医療支出の増加などの要因により拡大しています。

ジフテリアは、呼吸や食事に深刻な支障をきたし、皮膚潰瘍の可能性もあります。5価ワクチンの3回接種スケジュールは、子供をジフテリアから守ります。その結果、ジフテリアが一般的になるにつれ、5価ワクチンの需要が急増しました。このように、ジフテリアの有病率の上昇が市場成長の原動力となっています。例えば、国際保健規則（IHR）の報告プロセスでは、2022年に主に6月と8月にジフテリアの報告件数が異常に多かったことが記録されています。スイスに本部を置く国連の専門機関である世界保健機関（WHO）によると、7か国から144人のジフテリア症例が報告されており、その多くは難民でした。144人のうち、44人（31％）が検査室での確認により毒素原性ジフテリアと判明、97人（69％）が臨床的に適合、3人（2％）が疑い例でした。その結果、ジフテリアの発生が増加しており、市場は拡大しています。さらに、市場の主なプレーヤーによる戦略的イニシアチブの増加や、5価ワクチン開発活動への研究開発費の増加が、市場に有利な成長をもたらしています。しかし、5価ワクチン開発の初期費用が高く、認知度が低いことが、2023-2030年の予測期間を通じて市場の成長を阻害しています。

5価ワクチンの世界市場調査において考慮した主な地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、主要市場プレイヤーの優位性、同地域の疾患有病率の増加、研究開発活動への投資の増加により、2022年の市場を独占しました。アジア太平洋地域は、予測期間中に最も高いCAGRで成長すると予測されます。これは、新興国市場の発展、ワクチン開発のための共同研究件数の増加、主要企業の地理的拡大、政府機関や非営利団体の市場参入などの要因によるものです。

本調査の目的は、近年のさまざまなセグメントおよび国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や市場情勢の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
    • 5価ワクチン市場：地域別、2020-2030年
    • 5価ワクチン市場：タイプ別、2020-2030年
    • 5価ワクチン市場：製剤タイプ別、2020-2030年
    • 5価ワクチン市場：用途別、2020-2030年
  • 主要動向
  • 調査手法
  • 調査前提条件

第2章 5価ワクチンの世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 5価ワクチンの世界市場力学

  • 5価ワクチンの市場の影響分析（2020-2030年）
    • 市場促進要因
      • ジフテリア有病率の上昇
      • 予防接種プログラムの増加
    • 市場の課題
      • 5価ワクチン開発の初期コストの高さ
      • 治療法に関する認識不足
    • 市場機会
      • 5価ワクチン開発活動に対する研究開発費の増加
      • 主要市場プレイヤーによる戦略的イニシアチブの増加

第4章 世界の5価ワクチン市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 5価ワクチンの世界市場：タイプ別

  • 市場スナップショット
  • 5価ワクチンの世界市場：タイプ別、性能別、ポテンシャル分析
  • 5価ワクチンの世界市場：タイプ別推定・予測、2020-2030年
  • 5価ワクチン市場、サブセグメント分析
    • スチボグルコン酸ナトリウム
    • アンチモン酸メグルミン

第6章 5価ワクチンの世界市場：製剤タイプ別

  • 市場スナップショット
  • 5価ワクチンの世界市場：製剤タイプ別、性能-ポテンシャル分析
  • 5価ワクチンの世界市場：製剤タイプ別推定・予測2020-2030年
  • 5価ワクチン市場、サブセグメント分析
    • 凍結乾燥
    • 液体

第7章 5価ワクチンの世界市場：用途別

  • 市場スナップショット
  • 5価ワクチンの世界市場：用途別実績・ポテンシャル分析
  • 5価ワクチンの世界市場、用途別推定・予測2020-2030年
  • 5価ワクチン市場、サブセグメント分析
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第8章 5価ワクチンの世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 5価ワクチンの世界市場、地域別市場スナップショット
  • 北米
    • 米国
      • タイプ別推定・予測、2020-2030年
      • 製剤タイプの推定・予測、2020-2030年
      • 用途別推定・予測、2020-2030年
    • カナダ
  • 欧州の5価ワクチン市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の5価ワクチン市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの5価ワクチン市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Sanofi
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • GlaxoSmithKline PLC.
    • Bristol-Myers Squibb Company
    • Maiden Pharmaceuticals Limited
    • Shandong Xinhua Pharmaceutical Co.,Ltd.
    • Panacea Biotec Ltd.
    • Biological E. Ltd.
    • Novartis AG
    • Shantha Biotechnics Ltd.
    • Serum Institute of India Pvt. Ltd.

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Pentavalent Market, report scope
  • TABLE 2. Global Pentavalent Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Pentavalent Market estimates & forecasts by Type 2020-2030 (USD Billion)
  • TABLE 4. Global Pentavalent Market estimates & forecasts by Formulation Type 2020-2030 (USD Billion)
  • TABLE 5. Global Pentavalent Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 6. Global Pentavalent Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Pentavalent Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Pentavalent Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Pentavalent Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Pentavalent Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Pentavalent Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Pentavalent Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Pentavalent Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Pentavalent Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Pentavalent Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Pentavalent Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Pentavalent Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Pentavalent Market
  • TABLE 71. List of primary sources, used in the study of global Pentavalent Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Pentavalent Market, research methodology
  • FIG 2. Global Pentavalent Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Pentavalent Market, key trends 2022
  • FIG 5. Global Pentavalent Market, growth prospects 2023-2030
  • FIG 6. Global Pentavalent Market, porters 5 force model
  • FIG 7. Global Pentavalent Market, pest analysis
  • FIG 8. Global Pentavalent Market, value chain analysis
  • FIG 9. Global Pentavalent Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Pentavalent Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Pentavalent Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Pentavalent Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Pentavalent Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Pentavalent Market, regional snapshot 2020 & 2030
  • FIG 15. North America Pentavalent Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Pentavalent Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Pentavalent Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Pentavalent Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Pentavalent Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Pentavalent Market is valued at approximately USD 2.43 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2023-2030. Pentavalent is a kind of vaccine that protects against five different diseases: diphtheria, pertussis (whooping cough), tetanus, hepatitis B, and Haemophilus influenzae type b (Hib). It is called a "pentavalent" vaccine as it contains five different vaccines in one shot. The Pentavalent Market is expanding because of factors such as increasing government initiatives, increasing number of immunization programs, and rising healthcare expenditure.

Diphtheria results in serious difficulties breathing and eating, as well as the potential for skin ulcers. The three-dose schedule of the pentavalent vaccine protects children from diphtheria diseases; as a result, demand for pentavalent vaccines soared as diphtheria became more common. Thus, the rising prevalence of diphtheria is driving the market growth. For instance, the International Health Regulations (IHR) reporting process recorded an unusually high number of reported cases of diphtheria in 2022, primarily in the months of June and August. According to the World Health Organization, a specialized agency of the United Nations with headquarters in Switzerland. 144 cases of diphtheria have been reported from seven different countries, many of whom were refugees. Among 144 individuals, 44 (31%) were found to have toxigenic diphtheria by laboratory confirmation, 97 (69%) were found to be clinically compatible, and 3 (2%), suspected instances. As a result, the market is expanding because of the increasing occurrence of diphtheria. In addition, increasing strategic initiatives by the key market players and growing R&D spending on pentavalent vaccine development activities is creating lucrative growth in the market. However, the high initial cost of pentavalent development and lack of awareness stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Pentavalent Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players and the region's increasing disease prevalence, and rising investment in research and development activities. Asia Pacific is expected to grow at the highest CAGR during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for vaccine development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • Sanofi
  • GlaxoSmithKline PLC.
  • Bristol-Myers Squibb Company
  • Maiden Pharmaceuticals Limited
  • Shandong Xinhua Pharmaceutical Co.,Ltd.
  • Panacea Biotec Ltd.
  • Biological E. Ltd.
  • Novartis AG
  • Shantha Biotechnics Ltd.
  • Serum Institute of India Pvt. Ltd.

Recent Developments in the Market:

  • In December 2022, The United States Food and Drug Administration, a US federal agency of the Department of Health and Human Services, approved Pfizer's Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY in Adolescents), which is indicated for the prevention of meningococcal disease in people aged 10 to 25.
  • In January 2022, Ardian, a private equity investment firm with headquarters in France, acquired Biofarma Group. Ardian would be able to facilitate the market's further international expansion and consolidation with this acquisition. The Biofarma Group is an Italian business that competes in the market for pentavalent vaccines.

Global Pentavalent Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, Formulation Type, Application, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Sodium Stibogluconate
  • Meglumine Antimoniate

By Type:

  • Lyophilized
  • Liquid

By Application:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Pentavalent Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Pentavalent Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Pentavalent Market, by Formulation Type, 2020-2030 (USD Billion)
    • 1.2.4. Pentavalent Market, by Application, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Pentavalent Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Pentavalent Market Dynamics

  • 3.1. Pentavalent Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising prevalence of diphtheria
      • 3.1.1.2. Increasing number of immunization programs
    • 3.1.2. Market Challenges
      • 3.1.2.1. High initial cost of pentavalent development
      • 3.1.2.2. Lack of awareness regarding treatment availability
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing R&D spending on pentavalent vaccine development activities
      • 3.1.3.2. Increasing strategic initiatives by the key market players

Chapter 4. Global Pentavalent Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Pentavalent Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Pentavalent Market by Type, Performance - Potential Analysis
  • 5.3. Global Pentavalent Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Pentavalent Market, Sub Segment Analysis
    • 5.4.1. Sodium Stibogluconate
    • 5.4.2. Meglumine Antimoniate

Chapter 6. Global Pentavalent Market, by Formulation Type

  • 6.1. Market Snapshot
  • 6.2. Global Pentavalent Market by Formulation Type, Performance - Potential Analysis
  • 6.3. Global Pentavalent Market Estimates & Forecasts by Formulation Type 2020-2030 (USD Billion)
  • 6.4. Pentavalent Market, Sub Segment Analysis
    • 6.4.1. Lyophilized
    • 6.4.2. Liquid

Chapter 7. Global Pentavalent Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Pentavalent Market by Application, Performance - Potential Analysis
  • 7.3. Global Pentavalent Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 7.4. Pentavalent Market, Sub Segment Analysis
    • 7.4.1. Hospitals Pharmacies
    • 7.4.2. Retail Pharmacies
    • 7.4.3. Online Pharmacies

Chapter 8. Global Pentavalent Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Pentavalent Market, Regional Market Snapshot
  • 8.4. North America Pentavalent Market
    • 8.4.1. U.S. Pentavalent Market
      • 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Formulation Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Pentavalent Market
  • 8.5. Europe Pentavalent Market Snapshot
    • 8.5.1. U.K. Pentavalent Market
    • 8.5.2. Germany Pentavalent Market
    • 8.5.3. France Pentavalent Market
    • 8.5.4. Spain Pentavalent Market
    • 8.5.5. Italy Pentavalent Market
    • 8.5.6. Rest of Europe Pentavalent Market
  • 8.6. Asia-Pacific Pentavalent Market Snapshot
    • 8.6.1. China Pentavalent Market
    • 8.6.2. India Pentavalent Market
    • 8.6.3. Japan Pentavalent Market
    • 8.6.4. Australia Pentavalent Market
    • 8.6.5. South Korea Pentavalent Market
    • 8.6.6. Rest of Asia Pacific Pentavalent Market
  • 8.7. Latin America Pentavalent Market Snapshot
    • 8.7.1. Brazil Pentavalent Market
    • 8.7.2. Mexico Pentavalent Market
  • 8.8. Middle East & Africa Pentavalent Market
    • 8.8.1. Saudi Arabia Pentavalent Market
    • 8.8.2. South Africa Pentavalent Market
    • 8.8.3. Rest of Middle East & Africa Pentavalent Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Sanofi
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. GlaxoSmithKline PLC.
    • 9.3.3. Bristol-Myers Squibb Company
    • 9.3.4. Maiden Pharmaceuticals Limited
    • 9.3.5. Shandong Xinhua Pharmaceutical Co.,Ltd.
    • 9.3.6. Panacea Biotec Ltd.
    • 9.3.7. Biological E. Ltd.
    • 9.3.8. Novartis AG
    • 9.3.9. Shantha Biotechnics Ltd.
    • 9.3.10. Serum Institute of India Pvt. Ltd.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption